OptimizeRx Corp
Ticker: 1448431
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 19.84-23.9% | 26.07-10.7% | 29.20+33.2% | 21.93+2.9% | 21.31+13.3% | 18.81-4.5% | 19.69+20.6% | 16.33 |
| Total Income | 19.84-23.9% | 26.07-10.7% | 29.20+33.2% | 21.93+2.9% | 21.31+13.3% | 18.81-4.5% | 19.69+20.6% | 16.33 |
| EXPENSES | ||||||||
| Expenditure | 19.45-19.0% | 24.02-7.7% | 26.01+8.2% | 24.04-19.5% | 29.87+32.4% | 22.56-8.7% | 24.72+24.3% | 19.88 |
| Tax | -0.15-155.6% | 0.27+50.0% | 0.18+116.5% | -1.09-32.9% | -0.82+24.8% | -1.09-420.6% | 0.34 | — |
| PROFIT | ||||||||
| PBT | -0.64-161.0% | 1.05-38.6% | 1.71+152.1% | -3.28+67.0% | -9.94-94.9% | -5.10+22.3% | -6.56-128.6% | -2.87 |
| Net Profit | -0.50-164.1% | 0.78-49.0% | 1.53+169.5% | -2.20+75.9% | -9.12-127.4% | -4.01+41.9% | -6.90-140.4% | -2.87 |
| KEY METRICS | ||||||||
| OPM % | 2.00%-5.87pp | 7.86%-3.06pp | 10.92%+20.56pp | -9.64%+30.54pp | -40.18%-20.25pp | -19.93%+5.61pp | -25.54%-3.78pp | -21.76% |
| NPM % | -2.49%-5.48pp | 2.99%-2.26pp | 5.25%+15.28pp | -10.03%+32.79pp | -42.82%-21.51pp | -21.31%+13.73pp | -35.04%-17.49pp | -17.55% |
| EPS | -0.03-175.0% | 0.04-50.0% | 0.08+166.7% | -0.12+76.0% | -0.50-127.3% | -0.22+42.1% | -0.38-123.5% | -0.17 |
Corporate Events
Board MeetingOPRX
202615Jun
Board Meeting
Chief Commercial Officer Theresa Greco's separation from Opt…
SEC Filing ↗ Board MeetingOPRX
20269Jun
Board Meeting
Annual Meeting of Shareholders to elect directors, approve e…
SEC Filing ↗ Board MeetingOPRX
20263Apr
Board Meeting
Mary Varghese Presti appointed as a Director and Audit Commi…
SEC Filing ↗